ENHA 10-Q filed 2026-11-13 | Key takeaways
ENHA filed its 10-Q; the most relevant disclosure change is added Subsequent events - reverse stock split: Company effected 1-for-10 reverse stock split effective October 29, 2026; every ten shares of Class A and Class B common stock combined into one share; fractional shares rounded up; par value and authorized shares unchanged.
Key takeaways
Net loss improved to $13.5 million in Q3 2026 from $61.9 million in Q2 2026, as one-time costs of inaugural Enhanced Games and Business Combination did not recur
Company announced proposed acquisition of approximately 77% of DEAG Deutsche Entertainment AG from controlling shareholder Apeiron in exchange for approximately 10.97 million newly issued Class A shares, implying equity value of approximately €100 million ($115 million)
Company completed 1-for-10 reverse stock split effective October 29, 2026, with trading on split-adjusted basis beginning that date
Two sponsorship agreements accounted for substantially all sponsorship revenue for the nine months ended September 30, 2026; one settled in advertising/marketing services and one in equity securities of counterparty
Management concluded substantial doubt exists about company's ability to continue as going concern within twelve months due to recurring losses and need for additional capital
Company ended Q3 2026 with $12.1 million cash and cash equivalents, down from $19.6 million at June 30, 2026, and marketable securities of $8.1 million representing equity investment in Rezolve
Enhanced OS beta launched November 12, 2026, and HHS Peptide Policy enabled expanded peptide offerings effective November 3, 2026
Key metrics
Disclosure changes
- Subsequent events - reverse stock split
Company effected 1-for-10 reverse stock split effective October 29, 2026; every ten shares of Class A and Class B common stock combined into one share; fractional shares rounded up; par value and authorized shares unchanged
Reverse split reduces share count significantly and affects per-share metrics; all historical share and per-share data retroactively restated - Subsequent events - DEAG acquisition
Company announced proposed acquisition of approximately 77% of DEAG Deutsche Entertainment AG from Apeiron and other shareholders in exchange for approximately 10.97 million newly issued Class A shares; implied equity value of approximately €100 million ($115 million) for 100% of DEAG; concurrent $15 million private placement announced
Transformational acquisition would add scale in live entertainment and ticketing; related party transaction negotiated by special committee - Subsequent events - HHS peptide policy
HHS issued interim policy (October 28, 2026) not taking enforcement action against compounding six peptides; company began offering six additional peptides through Live Enhanced platform effective November 3, 2026
Regulatory development enables expanded peptide product offerings on Live Enhanced platform - Subsequent events - Enhanced OS launch
Company announced and launched beta version of Enhanced OS on November 12, 2026; AI-powered platform designed to provide personalized health, performance, and wellness solutions
New AI-powered platform represents significant product development for Live Enhanced business - Subsequent events - lock-up extension
Apeiron and CEO Maximilian Martin agreed to extend lock-up restrictions on 3.1 million shares through May 8, 2027; approximately 2.1 million shares released on November 8, 2026 instead of 5.2 million
Extension of lock-up restrictions affects float and potential selling pressure - Marketable securities
Company holds $8.1 million in marketable securities representing equity investment in Rezolve Ai PLC; received 3,731,343 Rezolve ordinary shares at $2.34 per share in September 2026; additional shares expected on December 23, 2026 to fulfill $10 million total consideration
Company holds equity position in sponsor; fair value changes affect financial results
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow ENHA in real time
Get material earnings, filing, IR, and earnings-call alerts by email.